Advanced Liver Cancer Treatment Developed By This Biotech Company
A New Hope in the Fight Against Advanced Liver Cancer: Can-Fite's Namodenoson Achieves Remarkable Results.
In an era where medical advancements are breaking boundaries, a new development has given hope to those battling advanced liver cancer. Can-Fite BioPharma Ltd., an Israeli biopharmaceutical company, announced that a patient treated with their drug Namodenoson showed a complete response and an impressive overall survival of 6.9 years.
